LL-37 (Cathelicidin)
Compounding-legalThe body's own broad-spectrum antimicrobial — biofilm disruption, chronic infection applications.
Mechanism
Antimicrobial cathelicidin. The body's own broad-spectrum antimicrobial — biofilm disruption, chronic infection applications. For full mechanism, dosing protocol, and stacking guidance, ask the AI Advisor or open the compound in-app.
Peer-Reviewed Studies (2)
LL-37 Biofilm Disruption
Disrupted bacterial biofilms at sub-inhibitory concentrations.
PubMed PMID 24820077 →Cathelicidin in Innate Immunity Review
Comprehensive review of LL-37 in innate immunity.
PubMed PMID 19390568 →